Clinical Trial Update: Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating bicalutamide implants (Biolen) with radiation therapy for localized prostate cancer. The study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Biolen

Snippet

Sponsor: Alessa Therapeutics Inc. | Conditions: Prostate Adenocarcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING